Conduit Pharmaceuticals I...
(CDT)
undefined
undefined%
At close: undefined
0.07
-1.24%
After-hours Jan 03, 2025, 05:58 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 |
| Revenue | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a |
| Operating Income | -5.56M | -3.16M | -3.17M |
| Interest Income | 15.00K | 1.98M | n/a |
| Pretax Income | -535.00K | -4.89M | -3.66M |
| Net Income | -535.00K | -4.89M | -3.66M |
| Selling & General & Admin | 5.47M | 3.05M | 2.89M |
| Research & Development | 90.00K | 111.00K | 283.00K |
| Other Expenses | n/a | n/a | n/a |
| Operating Expenses | 5.56M | 3.16M | 3.17M |
| Interest Expense | 211.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a |
| Cost & Expenses | 5.56M | 3.16M | 3.17M |
| Income Tax | -167.90K | 374.86K | 247.44K |
| Shares Outstanding (Basic) | 66.97M | 17.29M | 17.29M |
| Shares Outstanding (Diluted) | 67.89M | 17.29M | 17.29M |
| EPS (Basic) | -0.09 | -0.28 | -0.21 |
| EPS (Diluted) | -0.09 | -0.28 | -0.21 |
| EBITDA | -324.00K | -1.43M | -4.38K |
| Depreciation & Amortization | 167.90K | 1.73M | 484.00K |